Skip to main content
KIDSOrthoPediatrics Corp.Sell5.2·$19.95+3.37%
Open full analysis

OrthoPediatrics Corp. (KIDS) Stock Analysis

Breakout setup · Inst Constrain edge

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Devices

Sell if holding. Engine safety override at $19.95: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric... Read more

$19.95+7.6% A.UpsideScore 5.2/10#38 of 64 Medical Devices
QualityF-score6 / 9FCF yield-1.16%
Stop $18.55Target $21.46(analyst − 13%)A.R:R 0.5:1
Analyst target$24.67+23.6%9 analysts
$21.46our TP
$19.95price
$24.67mean
$17
$34

Sell if holding. Engine safety override at $19.95: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 66, MACD bullish. Score 5.2/10, moderate confidence.

Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 32d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Aug 5, 202632d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.4 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)-29.3
Mkt Cap$512M
EV/EBITDA-125.1
Profit Mgn-16.3%
ROE-11.6%
Rev Growth13.3%
Beta0.99
DividendNone
Rating analysts15

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

IV57%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
1.0
Support Resistance
2.2
52w Position
6.8

Unprofitable operations — net margin -16.3%. Quality floor flags this regardless of sector context.static

Roe
0.0
Roa
0.0
Operating Margin
0.0
Net Margin
0.0
Fcf Quality
0.0
Rule Of 40
3.0
Moat
6.5
Piotroski F
6.7
Current Ratio
7.8
Gross Margin
10.0
Cash-burning: FCF -2% of revenueRule of 40: 11 (fail)

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
3.1
Growth Rank
5.8
Value Rank
6.7
GatesA.R:R 0.5 < 1.5@spotMomentum 4.9<5.5 (soft — BUY_NOW allowed but watch)Momentum 4.9>=4.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 32d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
66 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $17.13Resistance $20.75

Price Targets

$19
$21
A.Upside+7.6%
A.R:R0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.4 < 4.0)
! asymmetry at 0.5 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-08-05 (32d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is KIDS stock a buy right now?

Sell if holding. Engine safety override at $19.95: Quality below floor (3.4 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 66, MACD bullish. Prior stop was $18.55. Score 5.2/10, moderate confidence.

What is the KIDS stock price target?

Take-profit target: $21.46 (+7.6% upside). Prior stop was $18.55. Stop-loss: $18.55.

What are the risks of investing in KIDS?

Quality below floor (3.4 < 4.0).

Is KIDS overvalued or undervalued?

OrthoPediatrics Corp. trades at a P/E of N/A (forward -29.3). TrendMatrix value score: 7.2/10. Verdict: Sell.

What do analysts say about KIDS?

15 analysts cover KIDS with a consensus score of 4.1/5. Average price target: $25.

What does OrthoPediatrics Corp. do?OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically...

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Related stocks: DCTH (Delcath Systems, Inc.) · BWAY (Brainsway Ltd.) · TCMD (Tactile Systems Technology, Inc) · ATEC (Alphatec Holdings, Inc.) · MOBI (Mobia Medical, Inc.)
Home Stocks KIDS

Latest news

No recent news